Key result
Each percentage point reduction in the risk-adjusted readmission rate for hip replacement was associated with an additional health gain of 0.004 for EQ-5D, indicating no unintended harm to patient outcomes.
Why the study?
Are reductions in hospital readmission rates associated with improvements in patient-reported health gains following hip and knee replacement?
Population
273,108 patients at NHS Trusts in England between April 2010 and February 2013.
Design
Cohort
Follow-up
6 months
Authors
Loading...
Reassures that hospital readmission reduction efforts do not compromise patient-reported quality of life.
Observational (n=273,108)
Yes
Are reductions in hospital readmission rates associated with improvements in patient-reported health gains following hip and knee replacement?
Mean Difference: 0.004 (95% CI 0.002–0.006)
p-value: p=<0.01
Reductions in hospital readmission rates following hip and knee replacement are associated with modest improvements in patient-reported health outcomes, suggesting that efforts to reduce readmissions do not negatively impact patient well-being.
Friebel et al. (2017) conducted an observational in Hip and knee replacement (n=273,108). Reduction in risk-adjusted 30-day readmission rate vs. Hospitals with lesser or no reduction in readmission rates was evaluated on Change in risk-adjusted health gain (EQ-5D) following hip replacement per 1 percentage point reduction in readmission rate (MD 0.004, 95% CI 0.002-0.006, p=<0.01). Each percentage point reduction in the risk-adjusted readmission rate for hip replacement was associated with an additional health gain of 0.004 for EQ-5D, indicating no unintended harm to patient outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: